Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05050110 · ClinicalTrials.gov registry record · NA
Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease
A NA study of Chronic Kidney Diseases, sponsored by Nand Wadhwa.
- Active
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT05050110: Active NA study of Chronic Kidney Diseases, sponsored by Nand Wadhwa.
NCT05050110 is a NA study of Chronic Kidney Diseases that is active but no longer recruiting, run by Nand Wadhwa. The registered enrollment target is 13 participants, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05050110, a NA study of Chronic Kidney Diseases, is active but no longer recruiting, sponsored by Nand Wadhwa.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer
Primary Outcome
Participants will increase the Fruit and vegetable consumption by following a Diet plan listed in the Nutritional Diary provided to them by the study site in the beginning of the study while taking Patiromer (Veltassa). This will record their daily intake of 26-28 servings of fruit and vegetables weekly. The Nutritional diary lists a Diet Plan that measures the serving size of 26-28 servings of the fruits and vegetables. The measurement of fruits and vegetables has been calculated by the Nutriti
Conditions Studied
Interventions
- OTHER Fruits and Vegetable increase
Study Locations (1)
New York
- NY Health - Port Jefferson Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05050110 still lists
NCT05050110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Fruits and Vegetable increase is the first listed.
NCT05050110 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05050110 about?
NCT05050110 is a clinical study titled "Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease". This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer
What is the current status of trial NCT05050110?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2020-11-24. Estimated completion is 2026-12.
What conditions does trial NCT05050110 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT05050110?
The interventions under investigation include: Fruits and Vegetable increase (OTHER).
Who is sponsoring clinical trial NCT05050110?
This trial is sponsored by Nand Wadhwa, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05050110 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05050110's enrollment target sits among peer trials
13 72nd of 73 higher than 2 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI